This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit July 08, 2015

Home  About Us  Advocacy   CSHP 2015   Events   Membership   Products & Publications   Programs Resources   Contact Us

 




Disclaimer: CSHP e-Newsbrief is a weekly listing featuring the latest news of interest to hospital pharmacists, selected from thousands of sources by the editors of MultiView. CSHP personnel approve the final summaries; any comments regarding content of this publication should be emailed to CSHP. It should not be understood or inferred from the presence of advertisements that CSHP endorses any products or services advertised. Similarly, CSHP is not responsible for the quality of journalism reflected in the articles: it should not be understood or inferred that CSHP supports the information provided. MultiView and CSHP are not liable, any delays or inaccuracies in the information contained in this brief, nor for any actions taken or outcomes resulting from relying on the information provided herein.



In this issue:

Report: Antipsychotics overprescribed to Quebec seniors with dementia
Tamper-resistant oxycodone called a 'gimmick' in growing opioid crisis
Ontario approves second costly drug for hepatitis C
Fentanyl present in 25 per cent of B.C. overdose deaths
Study: Diabetes drug helps people lose weight
Can a computer select the best cancer treatment?




Report: Antipsychotics overprescribed to Quebec seniors with dementia
CBC News
A new exposé conducted by a Quebec City newspaper suggests Quebec nursing homes are overmedicating seniors with dementia, despite multiple warnings from Health Canada warning against the usage of antipsychotics in this capacity. An investigative report by Le Soleil revealed that between 30 and 50 per cent of seniors with dementia in the province's CHSLDs are prescribed antipsychotic medications. That figure should be closer to 10 per cent, according to Philippe Voyer, a registered nurse and professor of nursing science at Université Laval in Quebec City.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Tamper-resistant oxycodone called a 'gimmick' in growing opioid crisis
CBC News
Some doctors are calling tamper resistant painkillers — designed to prevent people from crushing, snorting or injecting it for a quick high — a "gimmick" in the fight against Canada's growing opioid crisis. The comments were published recently in the Canadian Medical Association Journal, titled "Tamper-resistant drugs cannot solve the opioid crisis."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Ontario approves second costly drug for hepatitis C
Ottawa Citizen
With provincial approval of a second costly drug that can cure hepatitis C, Ottawa liver specialist Dr. Curtis Cooper is now expecting to see thousands of his patients cured of the disease that, without treatment, had the potential to destroy their lives. The Ontario government agreed recently to pay for the drug Holkira Pak which, pharmaceutical company AbbVie says had a 97 per cent cure rate in genotype 1 hepatitis C patients during clinical trials.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Fentanyl present in 25 per cent of B.C. overdose deaths
Metro News
Fentanyl was detected in a quarter of the province's illicit drug overdose deaths last year, according to a new report by the B.C. Centre for Disease Control. The report, published in the latest B.C. Medical Journal, highlights the rapid rise of the powerful synthetic opioid in communities throughout the continent. "While clusters of fentanyl-detected deaths have been reported in Canada and the U.S., these recent deaths represent an emerging public health concern in B.C.," the article says.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Program for pharmacists and pharmacy technicians

A unique online training program, developed by a team of experts and compliant with USP <797>, has just been launched by BCE Pharma. The program helps participants improve their knowledge and skills by watching videos related to compounding sterile preparations, filmed in a controlled environment. The participants also take part in online activities and quizzes to test their knowledge and answers are given in real time.

For more information call 1-514-544-5051 or visit www.bcepharma.com.
 


Study: Diabetes drug helps people lose weight
CP24
A new drug that was originally prescribed to diabetes patients might promise weight loss, a new study finds. Still, there are some side effects. In February 2015, the drug Liraglutide was approved to treat obesity in Canada. The injectable drug is marketed under the name Saxenda. It works by reducing the patient's appetite, making them eat less.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Can a computer select the best cancer treatment?
The Vancouver Sun
After IBM computer technology proved it was smarter than its champion human competitors in an epic $1 million Jeopardy tournament in 2011, scientists wondered: Might artificial intelligence do a better job than even highly trained physicians at predicting which drugs are best for cancer patients?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Discover Hospira's Specialty INJECTABLE Pharmaceuticals

Hospira's vision of integrity, accountability, and speed makes us a leading provider of a comprehensive line of high quality and cost effective generic injectables in Canada.

Learn more about Hospira's speciality injectable pharmaceuticals at www.hospira.ca or contact your Hospira Representative at 1-866-488-6088.
 


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Pharmacists play vital role in improving health of patients with Type 2 diabetes (News-Medical)
Quebec pharmacists granted more power by government (CBC News)
Fentanyl: The king of all opiates, and a killer drug crisis (Maclean's)

Don't be left behind. Click here to see what else you missed.
 


CSHP e-Newsbrief

Frank Humada, Director of Publishing, MultiView 289.695.5422
Download media kit

Joanne Lam, Senior Content Editor, MultiView 289.695.5474   
Contribute news


To unsubscribe, click here.

Recent issues

July 6, 2015 blast
July 1, 2015
June 24, 2015
June 17, 2015






50 Minthorn Blvd., Suite 800, Thornhill, ON, L3T 7X8